17 Nov

Illumina Continued to Rise, Led the Large-Cap Stocks

WRITTEN BY Peter Neil FEATURED IN Company News, Insights, & Analysis

IBB’s large-cap stocks fared better

The iShares Nasdaq Biotechnology ETF’s (IBB) large-cap stocks fared better than IBB. They had a return of 0.9% on November 16, 2015. The large-cap stocks have a weight of ~69.6% in IBB’s portfolio. Out of the 15 large-cap stocks that IBB holds in its portfolio, 11 stocks gave positive returns and four stocks ended up in red. The large-cap stocks in IBB include stocks like Mylan NV (MYL), Celgene (CELG), and Regeneron Pharmaceuticals (REGN). They had returns of 2.5%, 2.5%, and 1.8%, respectively.

Illumina Continued to Rise, Led the Large-Cap Stocks

The above graph shows a performance comparison of IBB’s large-cap stocks, IBB, and the SPDR S&P 500 ETF (SPY). Since the beginning of November to date, IBB’s large-cap stocks underperformed IBB and SPY. They had returns of -1.3%, -0.05%, and -1.1%, respectively.

Illumina will be in the S&P 500 Index

Illumina (ILMN) rose by 2.7% on November 16, 2015. It rose for the fourth consecutive trading session. Illumina rose 10% in the trailing five-day period. The stock rose due to its inclusion in the S&P 500 Index. It will replace Sigma-Aldrich (SIAL) in the S&P 500 after the close of trade on November 18. Merck KGaA acquired Sigma-Aldrich for an estimated value of $17 billion.

Illumina closed at $170.11. It was trading above the 20-day and 50-day moving averages. However, it was trading below the 100-day moving average. The stock’s RSI (Relative Strength Index) is at 60. This indicates that the stock isn’t overbought or oversold.

Illumina witnessed a rise in its trading volume. It’s important to note that ~3.1 million shares were being traded compared to the five-day average trading volume of ~2.04 million shares per day. The trailing 12-month PE (price-to-earnings) ratio stood at 49.59x. Illumina has a book value of $13.23 per share. With its current price, the stock is trading at a PBV (price-to-book value) ratio of 12.86x. Illumina has a weight of 3.6% in IBB’s portfolio.

Latest articles

Yesterday, Apple (AAPL) launched a newly upgraded range of its iPad Air and iPad mini devices ahead of its March 25 special event.

19 Mar

Nike Gears Up to Deliver Its Q3 2019 Results

WRITTEN BY Sharon Bailey

Nike (NKE) is scheduled to report its earnings results for the third quarter of fiscal 2019 after the market closes on March 21.

On March 18, Chesapeake Energy’s (CHK) implied volatility was 51.9%, which is ~14.7% less than its 15-day average.

19 Mar

Sprint’s Revenue and Earnings Growth

WRITTEN BY Andrew Smith

Sprint (S) reported an adjusted EPS of $0.06 in the first nine months of fiscal 2018—compared to $0.08 during the same period in fiscal 2017.

19 Mar

Oil Bulls: US Oil Exports Tend to Fall More

WRITTEN BY Robert Scott

On March 18, Brent crude oil May futures settled ~$8.2 higher than the WTI crude oil May futures. On March 11, the spread was ~$9.5.

Out of the 34 analysts covering Broadcom (AVGO), 25 analysts rated the stock a “buy,” while nine analysts rated the stock a “hold."